scholarly article | Q13442814 |
P50 | author | Paul Stewart | Q42887432 |
P2093 | author name string | Stephen M Prescott | |
P2860 | cites work | Hypertension and the cortisol-cortisone shuttle | Q28177024 |
Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues | Q28192400 | ||
Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age | Q28283140 | ||
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response | Q28286308 | ||
Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans | Q30486725 | ||
Cyclooxygenase-2 and carcinogenesis | Q33866664 | ||
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis | Q34156486 | ||
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities | Q34245387 | ||
Mechanisms of disease: Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome | Q36575445 | ||
Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression | Q37107024 | ||
Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells. | Q40334281 | ||
Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors | Q40678938 | ||
Prereceptor regulation of glucocorticoid action by 11beta-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation | Q40759887 | ||
Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene | Q42819964 | ||
Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors | Q43633880 | ||
Role of local 11 beta-hydroxysteroid dehydrogenase type 2 expression in determining the phenotype of adrenal adenomas | Q44306862 | ||
Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. | Q53425584 | ||
Repression of Cyclooxygenase-2 and Prostaglandin E2Release by Dexamethasone Occurs by Transcriptional and Post-transcriptional Mechanisms Involving Loss of Polyadenylated mRNA | Q58450602 | ||
LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR | Q60628255 | ||
Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide | Q67965056 | ||
Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders | Q73496694 | ||
Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice | Q73693790 | ||
Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in rats | Q73993916 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 760-763 | |
P577 | publication date | 2009-04-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Can licorice lick colon cancer? | |
P478 | volume | 119 |
Q37078077 | 11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal Tumorigenesis |
Q26779680 | Can active components of licorice, glycyrrhizin and glycyrrhetinic acid, lick rheumatoid arthritis? |
Q38790409 | Dysregulation of 11beta-hydroxysteroid dehydrogenases: implications during pregnancy and beyond. |
Q30545576 | Epithelial-specific deletion of 11β-HSD2 hinders Apcmin/+ mouse tumorigenesis |
Q57291363 | Harnessing the gatekeepers of glucocorticoids for chemoprevention of non-melanoma skin cancer |
Q42290255 | Identification and characterization of a 20β-HSDH from the anaerobic gut bacterium Butyricicoccus desmolans ATCC 43058. |
Q35641880 | Inhibition of 11β-Hydroxysteroid Dehydrogenase Type II Suppresses Lung Carcinogenesis by Blocking Tumor COX-2 Expression as Well as the ERK and mTOR Signaling Pathways |
Q33684718 | Licochalcone-E induces caspase-dependent death of human pharyngeal squamous carcinoma cells through the extrinsic and intrinsic apoptotic signaling pathways |
Q34006732 | Ligand-receptor interaction between triterpenoids and the 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) enzyme predicts their toxic effects against tumorigenic r/m HM-SFME-1 cells |
Q39739852 | Mouse 11β-hydroxysteroid dehydrogenase type 2 for human application: homology modeling, structural analysis and ligand-receptor interaction. |